《病理生物學(xué)》為對(duì)人類疾病的病理生理學(xué)和發(fā)病機(jī)制進(jìn)行高質(zhì)量的原始研究提供了一個(gè)有價(jià)值的論壇。該雜志旨在成為基礎(chǔ)生物醫(yī)學(xué)研究和臨床醫(yī)學(xué)之間的橋梁，歡迎來自病理學(xué)、腫瘤學(xué)、解剖學(xué)、病毒學(xué)、內(nèi)科學(xué)、外科學(xué)、細(xì)胞和分子生物學(xué)以及免疫學(xué)等科學(xué)領(lǐng)域的文章。這本雜志每?jī)蓚€(gè)月出版一期，內(nèi)容包括原始的研究論文、評(píng)論、簡(jiǎn)短的交流和社論。鼓勵(lì)發(fā)表強(qiáng)調(diào)病理數(shù)據(jù)臨床相關(guān)性的論文。一個(gè)特別部分將專門討論方法改進(jìn)方面的報(bào)告，在“國際論壇”部分，該領(lǐng)域的專家將討論當(dāng)前或有爭(zhēng)議的問題。

?Pathobiologyí offers a valuable forum for high quality original research into the pathophysiological and pathogenetic mechanisms underlying human disease. Aiming to serve as a bridge between basic biomedical research and clinical medicine, the journal welcomes articles from scientific areas such as pathology, oncology, anatomy, virology, internal medicine, surgery, cell and molecular biology, and immunology. Published bimonthly, the journal features original research papers, reviews, short communications and editorials. Papers highlighting the clinical relevance of pathological data are encouraged. A special section will be devoted to reports on methodological improvements, and in the ?International Forumí section current or controversial issues will be discussed by specialists in the field.